5PSQ-122 Experience of baricitinib-remdesivir use in patients with SARS-CoV-2 infection

Background and importanceThe rapid emergence of SARS-CoV-2 has led to the development of numerous treatments in a short period of time. The need for clinical expertise is vital for better care and follow-up of the hospitalized patient. Baricitinib and remdesivir are two treatments that can be used i...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of hospital pharmacy. Science and practice 2022-03, Vol.29 (Suppl 1), p.A157-A157
Hauptverfasser:	Gragera Gómez, M, Redondo Galán, C, Rivas Rodriguez, MD, Rojas Albarrán, A, Gil García, A, Rangel Mayoral, JF
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiviral drugs Conflicts of interest Drug therapy Section 5: Patient safety and quality assurance Severe acute respiratory syndrome coronavirus 2
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!